The ADHD omega-3 study is a clinical study in which one will research the effects of omega-3 on ADHD symptons at children with ADHD, like hyperactivity, impulsiveness and attention difficulties. Almost all children in the age of 6 – 16 with an ADHD diagnosis could participate in this clinical study BUP (Children and Youth Psychiatric Clinic).
The study is financed by the University Hospital of North Norway (UNN) and Helse Nord. Calanus AS is one of the external organizations that financially supports the study. The extrnal organizations have no direct economic interests in the research results, but can use these in future patent applications and for product information.
More information on the study and on how to participate can be found under ‘read more’
